10.1021/acs.molpharmaceut.9b00308 [DOI] [PubMed] 67.Guan Y, et al
There are very few medicines covered by Medicare that cost anywhere close to $35 billion over 10 years
This long-anticipated decision will allow dozens of cases to be consolidated in federal court, which can lead to a faster and more streamlined legal process
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
Additionally, in a phase I study, treatment of cagrilintide (up to 4.5 mg) combined with semaglutide (2.4 mg) resulted in greater body weight reduction than semaglutide (17% vs
However, the authors of this study noted that there were no clinically significant differences, and both drugs were effective for their intended uses